XLV holdings (2026)
All 59 positions in Health Care Select Sector SPDR Fund, ranked by portfolio weight — led by LLY at 15.8%. Weights come from the fund's own SEC N-PORT filing and update daily with prices; positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Weights are the Mar 31, 2026 SEC filing rolled forward on each holding's price move (as of market close, Aug 13, 2026) — an estimate of today, not the filed figure. Switch the table below to see them exactly as filed.
Top 10 holdings#
Sector weights#
Estimated portfolio characteristics#
Estimated by our own bottom-up analysis of the fund's SEC-filed holdings, covering 100% of portfolio weight (96% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
XLV holdings by weight#
1–59 of 59| # | Company | Weight | Price | 1D | YTD | 1Y | Mkt cap |
|---|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | 15.82% | $1,209.77 | -0.9% | +12.6% | +89.2% | $1.08T |
| 2 | JNJJohnson & Johnson | 10.42% | $262.13 | +0.5% | +26.7% | +51.7% | $632B |
| 3 | ABBVAbbVie Inc. | 7.32% | $250.84 | +0.8% | +9.8% | +26.3% | $443B |
| 4 | UNHUnitedHealth Group Incorporated Common Stock (DE) | 5.97% | $399.30 | -1.6% | +21.0% | +52.7% | $363B |
| 5 | MRKMerck & Co. Inc. | 5.55% | $135.58 | +2.0% | +28.8% | +68.8% | $335B |
| 6 | AMGNAmgen Inc. | 3.71% | $417.93 | +0.4% | +27.7% | +46.7% | $226B |
| 7 | TMOThermo Fisher Scientific Inc. | 3.70% | $596.04 | -1.2% | +2.9% | +24.8% | $220B |
| 8 | ABTAbbott Laboratories | 3.19% | $111.29 | +0.3% | -11.2% | -15.1% | $194B |
| 9 | GILDGilead Sciences Inc. | 2.83% | $138.14 | +1.7% | +12.5% | +15.1% | $171B |
| 10 | PFEPfizer Inc. | 2.51% | $26.80 | +1.8% | +7.6% | +8.7% | $153B |
| 11 | ISRGIntuitive Surgical Inc. | 2.35% | $401.34 | +0.0% | -29.1% | -16.1% | $142B |
| 12 | BMYBristol-Myers Squibb Company | 2.17% | $64.65 | +1.5% | +19.9% | +38.9% | $132B |
| 13 | VRTXVertex Pharmaceuticals Incorporated | 2.16% | $516.13 | -1.8% | +13.8% | +33.1% | $131B |
| 14 | DHRDanaher Corporation | 2.12% | $204.02 | -0.9% | -10.9% | -0.8% | $143B |
| 15 | CVSCVS Health Corporation | 1.99% | $95.02 | +0.3% | +19.7% | +45.0% | $122B |
| 16 | SYKStryker Corporation | 1.94% | $341.08 | -1.8% | -3.0% | -9.4% | $131B |
| 17 | MDTMedtronic plc. | 1.92% | $90.59 | -0.2% | -5.7% | -1.6% | $116B |
| 18 | MCKMcKesson Corporation | 1.73% | $856.87 | -2.5% | +4.5% | +30.0% | $100B |
| 19 | ELVElevance Health Inc. | 1.45% | $398.19 | -0.2% | +13.6% | +36.1% | $86B |
| 20 | REGNRegeneron Pharmaceuticals Inc. | 1.34% | $805.82 | +1.0% | +4.4% | +44.8% | $83B |
| 21 | BSXBoston Scientific Corporation | 1.27% | $51.71 | +0.6% | -45.8% | -49.6% | $75B |
| 22 | CIThe Cigna Group | 1.21% | $278.10 | +0.2% | +1.0% | -0.8% | $73B |
| 23 | HCAHCA Healthcare Inc. | 1.06% | $411.79 | -0.7% | -11.8% | +5.5% | $91B |
| 24 | CORCencora Inc. | 1.00% | $310.01 | -1.3% | -8.2% | +7.2% | $59B |
| 25 | CAHCardinal Health Inc. | 0.90% | $231.28 | -1.2% | +12.5% | +58.1% | $54B |
| 26 | EWEdwards Lifesciences Corporation | 0.89% | $92.56 | -0.5% | +8.6% | +20.3% | $53B |
| 27 | BDXBecton Dickinson and Company | 0.85% | $181.96 | -0.9% | +19.3% | +18.7% | $50B |
| 28 | HUMHumana Inc. | 0.77% | $384.97 | -1.0% | +50.3% | +40.0% | $46B |
| 29 | IDXXIDEXX Laboratories Inc. | 0.75% | $566.93 | -0.6% | -16.2% | -13.1% | $45B |
| 30 | AAgilent Technologies Inc. | 0.70% | $149.33 | +0.7% | +9.7% | +27.3% | $42B |
| 31 | IQVIQVIA Holdings Inc. | 0.68% | $241.53 | -0.1% | +7.2% | +29.9% | $40B |
| 32 | WATWaters Corporation | 0.67% | $413.52 | -0.6% | +8.9% | +44.8% | $41B |
| 33 | DXCMDexCom Inc. | 0.58% | $91.51 | +0.8% | +37.9% | +14.1% | $35B |
| 34 | GEHCGE HealthCare Technologies Inc. Common Stock | 0.56% | $73.80 | +2.1% | -10.0% | -0.8% | $34B |
| 35 | RMDResMed Inc. | 0.55% | $226.72 | +0.3% | -5.9% | -20.0% | $33B |
| 36 | ZTSZoetis Inc. | 0.53% | $75.83 | +3.1% | -39.7% | -49.4% | $31B |
| 37 | BIIBBiogen Inc. | 0.51% | $210.61 | +0.8% | +19.7% | +63.4% | $31B |
| 38 | CNCCentene Corporation | 0.51% | $66.05 | -1.5% | +60.5% | +152.4% | $33B |
| 39 | MTDMettler-Toledo International Inc. | 0.48% | $1,430.84 | -0.5% | +2.6% | +10.7% | $29B |
| 40 | LHLabcorp Holdings Inc. | 0.44% | $322.78 | -0.2% | +28.7% | +19.9% | $26B |
| 41 | DGXQuest Diagnostics Incorporated | 0.43% | $236.13 | -0.7% | +36.1% | +32.2% | $26B |
| 42 | WSTWest Pharmaceutical Services Inc. | 0.41% | $346.04 | -1.8% | +25.8% | +44.2% | $24B |
| 43 | STESTERIS plc (Ireland) | 0.38% | $236.07 | -0.2% | -6.9% | -3.2% | $23B |
| 44 | MRNAModerna Inc. | 0.37% | $63.65 | -0.0% | +115.8% | +148.1% | $25B |
| 45 | INCYIncyte Corp. | 0.33% | $120.49 | -0.2% | +22.0% | +47.6% | $24B |
| 46 | ZBHZimmer Biomet Holdings Inc. | 0.33% | $99.57 | +1.7% | +10.7% | -2.2% | $19B |
| 47 | VTRSViatris Inc. | 0.30% | $16.04 | -0.4% | +28.8% | +58.5% | $18B |
| 48 | Hologic Inc | 0.28% | — | — | — | — | — |
| 49 | COOThe Cooper Companies Inc. | 0.25% | $76.62 | -0.1% | -6.5% | +5.4% | $15B |
| 50 | BAXBaxter International | 0.23% | $27.05 | +0.4% | +41.5% | +12.8% | $14B |
| 51 | CRLCharles River Laboratories | 0.23% | $281.17 | -1.1% | +41.0% | +84.1% | $13B |
| 52 | RVTYRevvity Inc. | 0.22% | $117.46 | -0.4% | +21.4% | +33.5% | $13B |
| 53 | SOLVSolventum Corporation | 0.21% | $86.49 | +1.4% | +9.1% | +20.0% | $15B |
| 54 | ALGNAlign Technology Inc. | 0.19% | $176.10 | +1.2% | +12.8% | +25.3% | $13B |
| 55 | TECHBio-Techne | 0.19% | $72.18 | -0.1% | +22.7% | +36.6% | $11B |
| 56 | PODDInsulet Corporation | 0.17% | $146.34 | +0.9% | -48.5% | -52.7% | $10B |
| 57 | UHSUniversal Health Services | 0.16% | $171.19 | -0.7% | -21.5% | -2.3% | $10B |
| 58 | HSICHenry Schein | 0.15% | $90.12 | -0.7% | +19.2% | +33.5% | $10B |
| 59 | DVADaVita Inc. | 0.10% | $179.09 | -1.3% | +57.6% | +35.6% | $11B |
Methodology#
Holdings and weights are sourced from the fund's portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding's price move, keeping the numbers current between filings; positions in stocks ChartRow doesn't track carry their filed weight unchanged and show "—" where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet's GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of XLV?
- XLV's top 10 holdings are Eli Lilly and Company (LLY), 15.8%; Johnson & Johnson (JNJ), 10.4%; AbbVie Inc. (ABBV), 7.3%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 6.0%; Merck & Co. Inc. (MRK), 5.6%; Amgen Inc. (AMGN), 3.7%; Thermo Fisher Scientific Inc. (TMO), 3.7%; Abbott Laboratories (ABT), 3.2%; Gilead Sciences Inc. (GILD), 2.8%; Pfizer Inc. (PFE), 2.5% — together about 61% of the fund, per its Mar 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does XLV have?
- Health Care Select Sector SPDR Fund (XLV) held 59 positions as of its latest SEC N-PORT filing (Mar 31, 2026).
- How current are XLV's holdings?
- Funds disclose their full portfolio to the SEC on Form N-PORT; the quarter-end report becomes public about 60 days later. ChartRow anchors on the latest public filing (Mar 31, 2026) and rolls each weight forward daily by that holding's price move, so the weights shown estimate today rather than the filing date.
- Is ChartRow affiliated with XLV or State Street?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by State Street or Health Care Select Sector SPDR Fund. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.